Cigna Corporation (CI)
NYSE: CI
· Real-Time Price · USD
313.77
-0.63 (-0.20%)
At close: Jun 20, 2025, 3:59 PM
316.32
0.81%
After-hours: Jun 20, 2025, 05:42 PM EDT
Cigna Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 30, 2023 | Dec 30, 2022 | Dec 30, 2021 | Dec 30, 2020 | Dec 30, 2019 | Dec 30, 2018 |
|---|---|---|---|---|---|---|---|
| Cigna Healthcare Revenue | 47.53B | 46.82B | 42.38B | 42.38B | 36.47B | 35.34B | 32.22B |
| Cigna Healthcare Revenue Growth | +1.52% | +10.48% | -0.01% | +16.20% | +3.21% | +9.69% | n/a |
| Evernorth Revenue | 198.18B | n/a | n/a | n/a | n/a | n/a | n/a |
| Evernorth Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| United States Revenue | 241.56B | 189.84B | 174.54B | 166.63B | 154.04B |
| United States Revenue Growth | +27.25% | +8.77% | +4.75% | +8.17% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.21B | 3.87B | 3.59B | 3.68B | 3.71B | 4.06B | 3.79B | 3.43B | 3.54B | 3.48B | 3.15B | 3.26B | 3.27B | 3.66B | 3.09B | 3B | 3.28B | 3.97B | 3.3B | 3.41B | 3.4B | 3.96B | 3.41B | 3.38B | 3.3B | 200M | 2.87B | 2.84B | 2.75B | 9.96B | n/a | n/a | n/a | 82M | n/a | n/a | n/a | 92M | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | +9.00% | +7.66% | -2.55% | -0.57% | -8.79% | +7.23% | +10.31% | -2.94% | +1.58% | +10.54% | -3.46% | -0.34% | -10.57% | +18.40% | +3.24% | -8.63% | -17.32% | +20.15% | -3.11% | +0.26% | -14.13% | +15.94% | +0.98% | +2.33% | +1551.50% | -93.04% | +1.23% | +3.35% | -72.43% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |